Your browser doesn't support javascript.
Machine Learning Based Clinical Decision Support System for Early COVID-19 Mortality Prediction.
Karthikeyan, Akshaya; Garg, Akshit; Vinod, P K; Priyakumar, U Deva.
  • Karthikeyan A; Center for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad, India.
  • Garg A; Center for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad, India.
  • Vinod PK; Center for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad, India.
  • Priyakumar UD; Center for Computational Natural Sciences and Bioinformatics, International Institute of Information Technology, Hyderabad, India.
Front Public Health ; 9: 626697, 2021.
Article in English | MEDLINE | ID: covidwho-1247939
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
The coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, is an acute respiratory disease that has been classified as a pandemic by the World Health Organization (WHO). The sudden spike in the number of infections and high mortality rates have put immense pressure on the public healthcare systems. Hence, it is crucial to identify the key factors for mortality prediction to optimize patient treatment strategy. Different routine blood test results are widely available compared to other forms of data like X-rays, CT-scans, and ultrasounds for mortality prediction. This study proposes machine learning (ML) methods based on blood tests data to predict COVID-19 mortality risk. A powerful combination of five features neutrophils, lymphocytes, lactate dehydrogenase (LDH), high-sensitivity C-reactive protein (hs-CRP), and age helps to predict mortality with 96% accuracy. Various ML models (neural networks, logistic regression, XGBoost, random forests, SVM, and decision trees) have been trained and performance compared to determine the model that achieves consistently high accuracy across the days that span the disease. The best performing method using XGBoost feature importance and neural network classification, predicts with an accuracy of 90% as early as 16 days before the outcome. Robust testing with three cases based on days to outcome confirms the strong predictive performance and practicality of the proposed model. A detailed analysis and identification of trends was performed using these key biomarkers to provide useful insights for intuitive application. This study provide solutions that would help accelerate the decision-making process in healthcare systems for focused medical treatments in an accurate, early, and reliable manner.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Decision Support Systems, Clinical / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Front Public Health Year: 2021 Document Type: Article Affiliation country: Fpubh.2021.626697

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Decision Support Systems, Clinical / COVID-19 Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Front Public Health Year: 2021 Document Type: Article Affiliation country: Fpubh.2021.626697